tiprankstipranks
Microbot Medical Inc (GB:0K1B)
LSE:0K1B

Microbot Medical (0K1B) Share Price & Analysis

0 Followers

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%1.33%98.67%
0.00%
Insiders
0.00%
Mutual Funds
1.33% Other Institutional Investors
98.67% Public Companies and
Individual Investors

0K1B FAQ

What was Microbot Medical Inc’s price range in the past 12 months?
Currently, no data Available
What is Microbot Medical Inc’s market cap?
Currently, no data Available
When is Microbot Medical Inc’s upcoming earnings report date?
Microbot Medical Inc’s upcoming earnings report date is Mar 31, 2021 which is 1115 days ago.
    How were Microbot Medical Inc’s earnings last quarter?
    Microbot Medical Inc released its earnings results on Apr 14, 2020. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.28 by -$0.03.
      Is Microbot Medical Inc overvalued?
      According to Wall Street analysts Microbot Medical Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Microbot Medical Inc pay dividends?
        Microbot Medical Inc does not currently pay dividends.
        What is Microbot Medical Inc’s EPS estimate?
        Microbot Medical Inc’s EPS estimate is -$0.34.
          How many shares outstanding does Microbot Medical Inc have?
          Currently, no data Available
          What happened to Microbot Medical Inc’s price movement after its last earnings report?
          Microbot Medical Inc reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.28. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of Microbot Medical Inc?
            Currently, no hedge funds are holding shares in GB:0K1B
            ---

            Company Description

            Microbot Medical Inc

            Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
            ---

            0K1B Stock 12 Months Forecast

            Average Price Target

            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
            Similar Stocks
            Company
            Price & Change
            Follow
            Microbot Medical
            Medtronic
            Intuitive Surgical
            Abbott Labs
            Boston Scientific

            Best Analysts Covering 0K1B

            1 Year
            Ram SelvarajuH.C. Wainwright
            1 Year Success Rate
            1/8 ratings generated profit
            13%
            1 Year Average Return
            -39.21%
            reiterated a buy rating 6 months ago
            Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -39.21% per trade.
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis